Literature DB >> 11390999

Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse.

F D Shi1, M Flodstrom, B Balasa, S H Kim, K Van Gunst, J L Strominger, S B Wilson, N Sarvetnick.   

Abstract

Quantitative and qualitative defects in CD1-restricted natural killer T cells have been reported in several autoimmune-prone strains of mice, including the nonobese diabetic (NOD) mouse. These defects are believed to be associated with the emergence of spontaneous autoimmunity. Here we demonstrate that both CD1d-null NOD and CD1d-null NOD/BDC2.5 T cell receptor transgenic mice have an accelerated onset and increased incidence of diabetes when compared with CD1d(+/-) and CD1d(+/+) littermates. The acceleration of disease did not seem to result from changes in the T helper (Th)1/Th2 balance because lymphocytes purified from lymphoid organs and pancreatic islets of wild-type and CD1d-null mice secreted equivalent amounts of IFN-gamma and IL-4 after stimulation. In contrast, the pancreata of CD1d-null mice harbored significantly higher numbers of activated memory T cells expressing the chemokine receptor CCR4. Notably, the presence of these T cells was associated with immunohistochemical evidence of increased destructive insulitis. Thus, CD1d-restricted T cells are critically important for regulation of the spontaneous disease process in NOD mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390999      PMCID: PMC34429          DOI: 10.1073/pnas.121169698

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  The NOD mouse model of type 1 diabetes: as good as it gets?

Authors:  M A Atkinson; E H Leiter
Journal:  Nat Med       Date:  1999-06       Impact factor: 53.440

2.  Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells.

Authors:  G Eberl; H R MacDonald
Journal:  Eur J Immunol       Date:  2000-04       Impact factor: 5.532

Review 3.  Regulatory T cells in autoimmmunity*.

Authors:  E M Shevach
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 4.  Dissecting the role of CD4+ T cells in autoimmune diabetes through the use of TCR transgenic mice.

Authors:  A Suri; J D Katz
Journal:  Immunol Rev       Date:  1999-06       Impact factor: 12.988

5.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.

Authors:  B Salomon; D J Lenschow; L Rhee; N Ashourian; B Singh; A Sharpe; J A Bluestone
Journal:  Immunity       Date:  2000-04       Impact factor: 31.745

6.  The temporal importance of TNFalpha expression in the development of diabetes.

Authors:  E A Green; R A Flavell
Journal:  Immunity       Date:  2000-05       Impact factor: 31.745

7.  Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetes.

Authors:  S B Wilson; S C Kent; H F Horton; A A Hill; P L Bollyky; D A Hafler; J L Strominger; M C Byrne
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

8.  Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells.

Authors:  C Carnaud; D Lee; O Donnars; S H Park; A Beavis; Y Koezuka; A Bendelac
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

9.  A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus.

Authors:  M Falcone; B Yeung; L Tucker; E Rodriguez; N Sarvetnick
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

10.  CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site.

Authors:  K H Sonoda; M Exley; S Snapper; S P Balk; J Stein-Streilein
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

View more
  46 in total

1.  Genetic control of murine invariant natural killer T-cell development dynamically differs dependent on the examined tissue type.

Authors:  Y-G Chen; S-W Tsaih; D V Serreze
Journal:  Genes Immun       Date:  2011-09-22       Impact factor: 2.676

2.  CCR4-bearing T cells participate in autoimmune diabetes.

Authors:  Soon H Kim; Mary M Cleary; Howard S Fox; David Chantry; Nora Sarvetnick
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 3.  Innate self recognition by an invariant, rearranged T-cell receptor and its immune consequences.

Authors:  Aleksandar K Stanic; Jang-June Park; Sebastian Joyce
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

4.  Do NKT cells control autoimmunity?

Authors:  Lucienne Chatenoud
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

Review 5.  Genetic separation of the transplantation tolerance and autoimmune phenotypes in NOD mice.

Authors:  Todd Pearson; Thomas G Markees; David V Serreze; Melissa A Pierce; Linda S Wicker; Laurence B Peterson; Leonard D Shultz; John P Mordes; Aldo A Rossini; Dale L Greiner
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

6.  Subcongenic analysis of genetic basis for impaired development of invariant NKT cells in NOD mice.

Authors:  Yi-Guang Chen; John P Driver; Pablo A Silveira; David V Serreze
Journal:  Immunogenetics       Date:  2007-07-10       Impact factor: 2.846

7.  Type 1 diabetes and NKT cells: a report on the 3rd International Workshop on NKT cells and CD1-mediated antigen presentation, September 2004, Heron Island, QLD, Australia.

Authors:  Julie M Fletcher; Margaret A Jordan; Alan G Baxter
Journal:  Rev Diabet Stud       Date:  2004-11-10

Review 8.  The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.

Authors:  S L Cardell
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

9.  Testing the NKT cell hypothesis of human IDDM pathogenesis.

Authors:  Peter T Lee; Amy Putnam; Kamel Benlagha; Luc Teyton; Peter A Gottlieb; Albert Bendelac
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

10.  CD70 Inversely Regulates Regulatory T Cells and Invariant NKT Cells and Modulates Type 1 Diabetes in NOD Mice.

Authors:  Cheng Ye; Benjamin E Low; Michael V Wiles; Todd M Brusko; David V Serreze; John P Driver
Journal:  J Immunol       Date:  2020-08-31       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.